The Stop TB Partnership's Working Group on New Drugs presents a new podcast series entitled "The Dose". In this series, the WGND will bring together drug developers, researchers in the TB R&D field, TB patients, global health experts, and donors to discuss, prioritize, and develop strategies to help meet the most pressing needs faced by the TB drug R&D community.
Episode 1 "TB and the AMR Crisis"
Episode 1 will focus on TB and antimicrobial resistance (AMR). Today, AMR is one of the defining health issues of our time. Drug...